PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50322F80018 — LEUKINE 250MCG/VIL INJ

LEUKINE 250MCG/VIL INJ is a federal award for Department of Health and Human Services (HHS) held by PARTNER THERAPEUTICS, INC.. Estimated value $59M ($59M obligated). Current period of performance ends Mar 29, 2024. Last award drew 1 bidder. Place of performance: BOSTON, MA.

$59M
Estimated Value
Mar 29, 2024
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

PARTNER THERAPEUTICS, INC. holds $113.1M across 9 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Mar 29, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Contract facts

Federal
Contract number75A50322F80018
AgencyDepartment of Health and Human Services (HHS)
IncumbentPARTNER THERAPEUTICS, INC.
UEIJ33MSDBJZMC6
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79718D0593
Place of performanceBOSTON, MA
PoP end (current)Mar 29, 2024
Obligated$59M

Recompete timing

Public
Past PoP end (871 days ago)

Current PoP ended Mar 29, 2024 (871 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Watch this contract — one email →

Incumbent footprint

Public record

PARTNER THERAPEUTICS, INC.$113.1M obligated across 9 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($113.1M) · all agencies
Department of Health and Human Services (HHS)$113.1M · 100%Department of Veterans Affairs (VA)$91K · 0%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open PARTNER THERAPEUTICS, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50322F80018?

75A50322F80018 (LEUKINE 250MCG/VIL INJ) is a Department of Health and Human Services (HHS) award with an estimated value of $59M, currently held by PARTNER THERAPEUTICS, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50322F80018?

PARTNER THERAPEUTICS, INC. is the incumbent with $113.1M across 9 related awards in SCOUT’s public footprint. The current period of performance ends Mar 29, 2024.

When does 75A50322F80018 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 29, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36F79718D0593-75A50322F80018